Bio-Rad Laboratories, Inc.
BIONYSEHealthcare● Active
$293.87
$-0.45(-0.15%)
Market Cap$7.9B
P/E Ratio—
52W High$343.12
52W Low$218.14
Bio-Rad Laboratories, Inc.（BIO）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BIO · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.58B | $2.57B | $2.67B | $2.80B | $2.92B |
| Cost of Revenue | $1.24B | $1.19B | $1.24B | $1.23B | $1.28B |
| Gross Profit | $1.34B | $1.38B | $1.43B | $1.57B | $1.64B |
| Gross Margin %(computed) | 52.01% | 53.73% | 53.42% | 55.93% | 56.05% |
| Operating Expenses | |||||
| R&D Expenses | $0.26B | $0.30B | $0.25B | $0.26B | $0.26B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $1.08B | $1.11B | $1.09B | $1.08B | $1.14B |
| Operating Income | $0.27B | $0.27B | $0.34B | $0.48B | $0.50B |
| Operating Margin %(computed) | 10.47% | 10.48% | 12.65% | 17.22% | 17.12% |
| Interest Income | $0.10B | $0.08B | $0.10B | $0.06B | $0.02B |
| Interest Expense | $0.05B | $0.05B | $0.05B | $0.04B | $0.00B |
| Income Before Tax | $1.00B | ($2.34B) | ($0.85B) | ($4.70B) | $5.45B |
| Income Tax Expense | $0.24B | ($0.50B) | ($0.21B) | ($1.08B) | $1.19B |
| Net Income | $0.76B | ($1.84B) | ($0.64B) | ($3.63B) | $4.25B |
| Net Margin %(computed) | 29.42% | -71.86% | -23.86% | -129.45% | 145.57% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $27.87 | $-65.36 | $-21.82 | $-121.79 | $142.61 |
| Wtd Avg Shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| EBITDA | $0.48B | ($2.14B) | ($0.65B) | ($4.49B) | $5.59B |
| EBITDA Margin %(computed) | 18.42% | -83.46% | -24.51% | -160.19% | 191.21% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Bio-Rad Laboratories, Inc.
关于Bio-Rad Laboratories, Inc.（BIO）损益表
Bio-Rad Laboratories, Inc.（BIO）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，BIO实现营收$2.58B，毛利润$1.34B（毛利率52.01%），净利润$0.76B（净利率29.42%）。
常见问题
BIO · 4 问Bio-Rad Laboratories, Inc.（BIO）2025财年营收为$2.58B，同比up0.7%。
BIO revenueBIO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08